Thomas was Senior Vice President and Head of Clinical Development at Denovo Biopharma, and Vice President, Clinical Development and Translational Medicine at Halozyme Therapeutics. Thomas Heineman joined Oncolytics Biotech in 2020. Thomas served as Head of Global Clinical Development and Operations at Oncolytics Biotech.
Thomas Heineman is currently
Create your alert
to follow the career of Thomas Heineman.
Thomas Heineman has a Doctor of Medicine from University of Chicago and a PhD in Virology from University of Chicago.
They have also studied at University of Chicago :
Find more alumni from University of Chicago
They have also studied at University of Chicago :
Find more alumni from University of Chicago
Do you need to know more about Thomas Heineman? More results.
Report an error
Update the org chart details of Thomas Heineman.
Here are a few tips for establishing great contacts.
Discover the organization charts of your favorite companies.
Spot the influential executives using our search tools.
Receive notifications when executive positions change.